This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Carbon Dioxide Air Mixture

Read time: 1 mins
Marketing start date: 23 Dec 2024
...
 

Summary of product characteristics


Effective Time

20231018

Version

7

Spl Product Data Elements

Carbon Dioxide Air Mixture Carbon Dioxide Air Mixture CARBON DIOXIDE CARBON DIOXIDE OXYGEN

Application Number

NDA205852

Brand Name

Carbon Dioxide Air Mixture

Generic Name

Carbon Dioxide Air Mixture

Product Ndc

21220-157

Product Type

HUMAN PRESCRIPTION DRUG

Route

RESPIRATORY (INHALATION)

Package Label Principal Display Panel

COMPRESSED GAS, N.O.S. (95% AIR USP, 5% CARBON DIOXIDE USP) UN1956 NON-FLAMMABLE GAS 2 37138 (R04/06) Rx only WARNING: Administration of this gas mixture may be hazardous or contraindicated. For use only by or under the supervision of a licensed practitioner who is experienced in the use and administration of gas mixtures, and is familiar with the indications, effects, dosages, methods, and frequency and duration of administration and with the hazards, contraindications and side effects and the precautions to be taken. CAUTION: HIGH PRESSURE GAS. MAY ACCELERATE COMBUSTION. CAN INCREASE RESPIRATION AND HEART RATE. Keep oil and grease away. Store and use with adequate ventilation. Use only with equipment cleaned for oxygen service and rated for cylinder pressure. Use a back flow preventive device in the piping. Cylinder temperature should not exceed 52C (125F). Open valve slowly. Close valve after each use and when empty. Use in accordance with the Material Safety Data Sheet (MSDS). FIRST AID: IF INHALED, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Call a physician. AIR CAS 132259-10-0 CARBON DIOXIDE CAS: 124-38-9 DO NOT REMOVE THIS PRODUCT LABEL FILLED and INSPECTED BY GENERAL AIR SERVICE and SUPPLY DENVER, CO 80204 303-892-7003 co2 air

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.